ATH 0.00% 0.3¢ alterity therapeutics limited

Voice of the Patient - FDA Summary of HD meeting, page-2

  1. 115 Posts.
    Thanks ITM as usual. This report is very hard reading - in terms of the pain and suffering of the patients with HD and their families and carers. Here's hoping that our little drug (PBT2) can soon be at least trialled for these patients as several commented they would be happy to participate in drug testing trials as they at least need hope. And unlike us as investors who can wait for due process, they don't have time!!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $12.53K 4.143M

Buyers (Bids)

No. Vol. Price($)
3 13926044 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 153031722 56
View Market Depth
Last trade - 14.56pm 19/11/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.